Beryl Drugs Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 20.967 million compared to INR 23.644 million a year ago. Operating loss was INR 2.689 million compared to operating Income of INR 1.975 million a year ago. Net loss was INR 1.703 million compared to net income of INR 924,000 a year ago. Basic loss per share from continuing operations was INR 0.34 compared to basic earnings per share from continuing operations of INR 0.18 a year ago. For the nine months, total revenue was INR 86.055 million compared to INR 99.383 million a year ago. Operating income was INR 323,000 compared to INR 7.745 million a year ago. Net income was INR 1.224 million compared to INR 5.695 million a year ago. Basic earnings per share from continuing operations was INR 0.24 compared to INR 1.12 a year ago.